You are here
As prescribed in Section 225 of the National Health Reform Act 2011 (the Act), the objectives of the IHPA Work Program are to:
- set out IHPA’s work program for the coming year; and
- invite interested persons (including states and territories) to make submissions to the Pricing Authority about the work program up to 30 days after publication.
An extract of Section 225 of the Act is attached at Appendix 1.
The Tier 2 Non-Admitted Services Compendium provides guidance on the counting and classification rules associated with the Tier 2 Non-Admitted Services Classification (Tier 2).
The Tier 2 Non-Admitted Services Classification (Tier 2) supports the introduction of activity based funding (ABF) for non-admitted hospital services in the Australian public hospital system.
The Australian Hospital Patient Costing Standards (AHPCS) provide direction for hospital patient costing through the development of standards for specific elements of the costing process and reporting requirements.
The AHPCS Version 4.0 was developed through extensive consultation with jurisdictions and stakeholders. The AHPCS Version 4.0 comprises:
This report presents the results of phase one of the project to develop Australian Refined Diagnosis Related Groups (AR-DRG)1 Version (V) 8.0. This phase focuses on the case complexity component of the classification that has not been reviewed for many years
The non-admitted study was comprehensive across a range of settings (e.g. outpatients, community and satellite clinics). Similarly all service streams were included regardless of funding source. This ensured that all services were accounted for and costed appropriately providing an accurate cost of delivering multiple services across multiple settings (e.g. overhead costs are apportioned across all patients).
The costing study on home delivered dialysis was undertaken in 2014. The purpose of the study was to collate and compare the range of costing studies and economic evaluations that have been carried out on these services over the past decade.
The report identifies two key studies - NSW Dialysis Costing Study, conducted in 2008, and Queensland Health Renal Replacement Therapy Costing Study, conducted in 2008 - which are useful in estimating the current costs of home-based dialysis.
PwC and its sub-contractor The Independent Hospital Pricing Authority (IHPA) engaged PwC and its sub-contractor SyRis Consulting to undertake a review and costing study of Australian radiotherapy services. The study was commissioned to determine the reliability of radiotherapy cost data due to its role in the development of associated price weights in both admitted and non-admitted settings.
Submissions were forwarded to IHPA in a range of formats including Word, RTF, PDF and handwritten or typed hardcopy. In order to make submissions available as soon as possible, most submissions have been published in their original format. Handwritten submissions have been scanned into PDF documents. If the content has been emailed to IHPA the text of email submissions has been reproduced in Word format.